cardiac fibroblast female adult
HTR-8/SVneo
epidermal melanocyte
frontal cortex male adult (27 years) and male adult (35 years)
MCF 10A treated with 1 μM tamoxifen for 6 hours
GM06990
MCF-7 genetically modified using RNAi
glomerular endothelial cell
right arm bone male embryo (81 days)
chorion
right leg bone male embryo (81 days)
GM03348
fibroblast of the conjunctiva
brain pericyte
dermis blood vessel endothelial cell female adult
retinal pigment epithelial cell
lung microvascular endothelial cell female
GM03348 genetically modified using transduction treated with 3 μg/mL doxycycline for 10 days
GM12864
heart male adult (27 years) and male adult (35 years)
MCF-7 genetically modified using RNAi
hepatic stellate cell female adult (59 years)
GM04504
GM04503
iris pigment epithelial cell
dermis blood vessel endothelial cell male newborn
T-helper 2 cell female adult (26 years)
T-helper 2 cell male adult (33 years)
adrenal gland female embryo (85 days)
foreskin fibroblast male newborn
placenta female embryo (85 days)
large intestine female embryo (105 days)
MCF-7
lung microvascular endothelial cell female
dermis blood vessel endothelial cell male newborn
CMK
T-helper 1 cell male adult (33 years)
epithelial cell of prostate
fibroblast of the aortic adventitia female
epithelial cell of proximal tubule
fibroblast of skin of upper back male embryo (97 days)
lung embryo (67 days)
lung female embryo (120 days)
K562 G1 phase
LNCaP clone FGC
left renal cortex interstitium male embryo (120 days)
non-pigmented ciliary epithelial cell
fibroblast of peridontal ligament male
placenta embryo (102 days)
cardiac fibroblast
T-cell male adult (37 years)
CD4-positive, alpha-beta T cell male adult (21 years) treated with 7.5 μg/kg G-CSF for 4 days
right lung female embryo (108 days)
adrenal gland male embryo (108 days)
osteoblast
CD8-positive, alpha-beta T cell male adult (37 years)
left arm bone male embryo (81 days)
stomach male embryo (127 days)
heart female embryo (117 days)
GM12878
keratinocyte female
ovary female adult (30 years)
GM12878
right lung female embryo (117 days)
large intestine female embryo (120 days)
fibroblast of mammary gland female
spinal cord male embryo (96 days)
fibroblast of skin of left biceps male embryo (97 days)
GM18507
left kidney female embryo (110 days)
right renal pelvis male embryo (105 days)
right renal pelvis male embryo (105 days)
HS-27A
stomach female embryo (107 days)
left leg bone male embryo (81 days)
stomach male child (3 years)
adrenal gland female embryo (108 days)
large intestine female embryo (107 days)
right kidney male embryo (87 days)
brain male embryo (105 days)
urothelium cell line
frontal cortex female adult (67 years) and female adult (80 years)
MCF-7 treated with 10 mM lactate for 24 hours
endothelial cell of umbilical vein newborn
T-helper 1 cell female adult (26 years)
NT2/D1
GM12892
muscle of leg female embryo (85 days)
CD4-positive, alpha-beta T cell male adult (37 years)
right renal pelvis male embryo (120 days)
renal pelvis male embryo (108 days)
muscle of trunk female embryo (120 days)
CD4-positive, alpha-beta T cell female adult (33 years)
adrenal gland male embryo (85 days)
left lung female embryo (98 days)
stomach female embryo (147 days)
muscle of arm male embryo (104 days)
left kidney female embryo (98 days)
renal cortex interstitium male embryo (108 days)
GM12865
K562 G2 phase
right lung male embryo (105 days)
C803
muscle of back male embryo (104 days)
HK-2
right lung female embryo (110 days)
regulatory T cell male adult (28 years)
germinal center
LNCaP clone FGC
MCF-7 treated with 100 nM estradiol for 1 hour
placenta female embryo (105 days)
dermis blood vessel endothelial cell female adult
hematopoietic multipotent progenitor cell
T-helper 17 cell
muscle of leg male embryo (96 days)
HuH-7.5
MCF-7
pulmonary artery endothelial cell female
stomach female embryo (121 days)
muscle of leg male embryo (115 days)
muscle of arm female embryo (98 days)
muscle of arm male embryo (96 days)
iPS-NIHi11 originated from AG20443
common myeloid progenitor, CD34-positive male adult (36 years)
B cell female adult (34 years)
AG08396
muscle of arm embryo (101 days)
muscle of leg male embryo (96 days)
muscle of arm male embryo (127 days)
muscle of back male embryo (108 days)
fibroblast of pulmonary artery
lung male embryo (108 days)
right lung female embryo (98 days)
left renal pelvis male embryo (105 days)
D721Med
heart female embryo (110 days)
muscle of arm male embryo (101 days)
muscle of arm female embryo (115 days)
spinal cord female embryo (113 days)
K562 treated with 1 μM vorinostat for 72 hours
CD4-positive, alpha-beta T cell male adult (21 years)
placenta male embryo (85 days)
renal cortex interstitium male embryo (113 days)
EL
left renal pelvis male embryo (105 days)
renal pelvis female embryo (96 days)
thymus female embryo
fibroblast of villous mesenchyme
adrenal gland embryo (96 days)
skin of body female embryo (82 days)
naive thymus-derived CD4-positive, alpha-beta T cell female adult (35 years)
right lung female embryo (105 days)
NB4
left lung male embryo (113 days)
small intestine male embryo (108 days)
common myeloid progenitor, CD34-positive female adult (50 years)
stomach female embryo (105 days)
small intestine female embryo (120 days)
common myeloid progenitor, CD34-positive male adult (37 years)
natural killer cell male adult (37 years)
GM10266
left lung female embryo (91 days)
adrenal gland male embryo (101 days)
WI38 genetically modified using stable transfection originated from WI38
HepG2
fibroblast of skin of right biceps male embryo (97 days)
brain male embryo (101 days)
common myeloid progenitor, CD34-positive male adult (49 years)
muscle of back male embryo (96 days)
naive B cell
left lung female embryo (105 days)
B cell male adult (37 years)
right kidney female embryo (107 days)
lung embryo (112 days)
muscle of leg male embryo (127 days)
thymus female embryo (147 days)
thymus male embryo (127 days)
muscle of trunk female embryo (113 days)
renal cortex interstitium male embryo (97 days)
left lung male embryo (105 days)
muscle of arm male embryo (120 days)
T-cell
left lung male embryo (96 days)
large intestine male embryo (105 days)
heart male embryo (120 days)
T-cell male adult (21 years) treated with 7.5 μg/kg G-CSF for 4 days
lung male embryo (103 days)
kidney female embryo (105 days)
brain male embryo (122 days)
natural killer cell female adult (34 years)
brain female embryo (109 days)
foreskin keratinocyte male newborn
CD8-positive, alpha-beta T cell female adult (34 years)
right renal cortex interstitium male embryo (105 days)
COLO829
muscle of leg male embryo (104 days)
kidney female embryo (121 days)
choroid plexus epithelial cell
iPS DF 19.7
CD4-positive, alpha-beta T cell male adult (37 years) treated with 7.5 μg/kg G-CSF for 4 days
small intestine female embryo (105 days)
small intestine female embryo (98 days)
right lung female embryo (91 days)
large intestine female embryo (103 days)
WI38 genetically modified using stable transfection originated from WI38 treated with 20 nM afimoxifene for 72 hours
forelimb muscle female embryo (108 days)
thymus male embryo (104 days)
renal cortex interstitium male embryo (127 days)
left kidney female embryo (87 days)
fibroblast of skin of scalp male embryo (97 days)
heart embryo (101 days)
right lung male embryo (115 days)
fibroblast of skin of left biceps male embryo (97 days)
fibroblast of skin of back male embryo (97 days)
small intestine female embryo (108 days)
common myeloid progenitor, CD34-positive male adult (23 years)
left lung male embryo (115 days)
large intestine female embryo (98 days)
right lung male embryo (96 days)
GM10248
HL-60
muscle of arm male embryo (96 days)
lung male embryo (82 days)
fibroblast of skin of left quadriceps male embryo (97 days)
kidney male embryo (87 days)
common myeloid progenitor, CD34-positive male adult (42 years)
GM19238
renal cortical epithelial cell
muscle of arm male embryo (97 days)
fibroblast of skin of upper back male embryo (97 days)
spinal cord female embryo (87 days)
muscle of leg male embryo (105 days)
muscle of leg male embryo (97 days)
stomach female embryo (96 days)
T-cell male adult (21 years)
muscle of back female embryo (98 days)
AG09309
hindlimb muscle male embryo (120 days)
right kidney male embryo (115 days)
stomach male embryo (91 days)
K562 treated with 500 μM sodium butyrate for 72 hours
brain female embryo (117 days)
lung embryo (101 days)
small intestine male embryo (105 days)
RWPE1
CD8-positive, alpha-beta T cell male adult (21 years)
common myeloid progenitor, CD34-positive male adult (43 years)
CD14-positive monocyte male adult (37 years)
spleen embryo (112 days)
muscle of back female embryo (113 days)
right kidney female embryo (87 days)
AG20443
LNCaP clone FGC treated with 1 nM 17β-hydroxy-17-methylestra-4,9,11-trien-3-one for 12 hours
right kidney male embryo (96 days)
thymus female embryo (113 days)
left kidney female embryo (107 days)
muscle of back female embryo (105 days)
heart male embryo (96 days)
heart male child (3 years)
heart male embryo (110 days)
stomach female embryo (96 days)
muscle of leg male embryo (97 days)
right renal cortex interstitium male embryo (105 days)
renal cortex interstitium female embryo (96 days)
left kidney female embryo (147 days)
renal pelvis male embryo (91 days)
heart female embryo (91 days)
brain female embryo (142 days)
common myeloid progenitor, CD34-positive male
renal pelvis female embryo (103 days)
fibroblast of skin of scalp male embryo (97 days)
left lung female embryo (108 days)
GM23248
placenta female embryo (108 days)
CD8-positive, alpha-beta T cell male adult (21 years) treated with 7.5 μg/kg G-CSF for 4 days
renal cortex interstitium male embryo (108 days)
bipolar neuron originated from GM23338 treated with 0.5 μg/mL doxycycline hyclate for 4 days
GM19240
muscle of back female embryo (105 days)
renal cortex interstitium female embryo (96 days)
bronchial epithelial cell female treated with 6 μM retinoic acid for 48 hours
muscle of back male embryo (97 days)
naive thymus-derived CD4-positive, alpha-beta T cell
thymus female embryo (98 days)
renal cortex interstitium female embryo (120 days)
placenta male embryo (91 days)
kidney female embryo (120 days)
GM23338 originated from GM23248
left renal pelvis male embryo (105 days)
CD8-positive, alpha-beta T cell female adult (33 years)
kidney female embryo (105 days)
kidney male embryo (85 days)
stomach female embryo (98 days)
muscle of leg male embryo (101 days)
stomach male embryo (108 days)
stomach female embryo
foreskin fibroblast male newborn
right lung female embryo (107 days)
muscle of arm female embryo (120 days)
testis male embryo
common myeloid progenitor, CD34-positive female adult (27 years)
right kidney female embryo (98 days)
HFF-Myc originated from foreskin fibroblast
stomach female embryo (105 days)
muscle of leg female embryo (113 days)
small intestine male embryo (87 days)
left lung female embryo (107 days)
spinal cord male embryo (105 days)
left lung male embryo (91 days)
brain female embryo (85 days)
stomach female embryo (108 days)
left kidney male embryo (87 days)
foreskin fibroblast male newborn
thymus male embryo (113 days)
right kidney female embryo (117 days)
left kidney male embryo (96 days)
left renal cortex interstitium male embryo (105 days)
muscle of arm female embryo (105 days)
astrocyte of the spinal cord
kidney female embryo (85 days)
muscle of leg female embryo (105 days)
muscle of back male embryo (91 days)
small intestine female embryo (91 days)
common myeloid progenitor, CD34-positive female
left lung female embryo (110 days)
left renal cortex interstitium male embryo (105 days)
iPS DF 4.7
lung female embryo (108 days)
iPS DF 6.9
small intestine female embryo (110 days)
natural killer cell male adult (21 years)
HeLa-S3
brain embryo (112 days)
left lung female embryo (117 days)
renal cortex interstitium female embryo (103 days)
spinal cord female embryo (89 days)
T-cell male adult (36 years)
renal pelvis female embryo (96 days)
right renal pelvis male embryo (105 days)
A549
muscle of back female embryo (115 days)
stomach embryo (101 days)
large intestine female embryo (91 days)
testis male embryo
large intestine female embryo (108 days)
lung female embryo (96 days)
foreskin keratinocyte male newborn
muscle of arm male embryo (97 days)
IMR-90
brain female embryo (105 days)
adrenal gland female embryo (113 days)
heart female embryo (105 days)
kidney female embryo (108 days)
renal pelvis female embryo (89 days)
kidney female embryo (113 days)
left renal pelvis male embryo (120 days)
small intestine male embryo (115 days)
renal pelvis male embryo (127 days)
brain male embryo (104 days)
foreskin melanocyte male newborn
left lung male embryo (87 days)
WERI-Rb-1
stromal cell of bone marrow male
muscle of arm male embryo (115 days)
lung female embryo (85 days)
M059J
thymus female embryo (105 days)
right renal cortex interstitium male embryo (120 days)
heart female embryo (147 days)
H54
hepatocyte
BJ
large intestine male embryo (91 days)
large intestine male embryo (108 days)
right kidney female embryo (147 days)
ELR
heart embryo (96 days)
ovary female embryo
renal pelvis female embryo (105 days)
placenta female embryo (113 days)
left kidney male embryo (115 days)
right kidney male embryo (108 days)
HuH-7
astrocyte of the hippocampus
heart female embryo (103 days)
muscle of back female embryo (85 days)
amniotic epithelial cell
cardiac muscle cell
muscle of leg female embryo (115 days)
muscle of arm male embryo (105 days)
kidney epithelial cell
epithelial cell of esophagus
Ishikawa treated with 0.02% dimethyl sulfoxide for 1 hour
large intestine female embryo (110 days)
muscle of back male embryo (105 days)
fibroblast of skin of right quadriceps male embryo (97 days)
common myeloid progenitor, CD34-positive female adult (33 years)
CD14-positive monocyte female adult (34 years)
kidney male embryo (105 days)
left renal cortex interstitium male embryo (105 days)
small intestine female embryo (107 days)
thymus male embryo (108 days)
pancreas female adult (30 years)
muscle of back male embryo (96 days)
renal cortex interstitium female embryo (89 days)
GM12891
foreskin melanocyte male newborn
CWRU1
psoas muscle male adult (27 years) and male adult (35 years)
dermis microvascular lymphatic vessel endothelial cell male
D341Med
muscle of trunk female embryo (121 days)
large intestine male embryo (113 days)
AG10803
small intestine male embryo (91 days)
right lung male embryo (87 days)
8988T
HFFc6
common myeloid progenitor, CD34-positive male adult
Caco-2
muscle of arm female embryo (85 days)
muscle of arm male embryo (113 days)
astrocyte of the cerebellum
T-helper 1 cell
iPS-NIHi7 originated from AG08395
dermis microvascular lymphatic vessel endothelial cell female
CD14-positive monocyte male adult (21 years)
fibroblast of skin of left quadriceps male embryo (97 days)
retina embryo (125 days) and male embryo (103 days)
GM19239
muscle of back male embryo (127 days)
HS-5
brain microvascular endothelial cell
fibroblast of gingiva
foreskin fibroblast male newborn
MCF-7 originated from MCF-7
fibroblast of skin of abdomen male embryo (97 days)
iPS DF 19.11
T-helper 2 cell
heart male embryo (105 days)
smooth muscle cell of the brain vasculature female
renal cortex interstitium male embryo (91 days)
retina embryo (74 days) and embryo (85 days)
SK-N-SH treated with 6 μM all-trans-retinoic acid for 48 hours
K562
brain female embryo (96 days)
fibroblast of lung
T-helper 1 cell
large intestine male embryo (115 days)
right atrium auricular region female adult (51 years)
heart left ventricle female embryo (136 days)
muscle of back male embryo (101 days)
bronchial epithelial cell
naive thymus-derived CD4-positive, alpha-beta T cell male adult (26 years)
renal pelvis male embryo (97 days)
renal pelvis male embryo (113 days)
SK-N-MC
sigmoid colon male adult (54 years)
mesendoderm originated from H1
stomach male adult (54 years)
endothelial cell of umbilical vein newborn
large intestine male embryo (105 days)
SK-N-DZ treated with dimethyl sulfoxide for 72 hours
SK-MEL-5
CD14-positive monocyte female
HPDE6-E6E7
K562 treated with 0.05% dimethyl sulfoxide for 72 hours
pancreas male adult (34 years)
AG09319
AG08395
Jurkat clone E61
coronary artery female adult (51 years)
Ishikawa treated with 600 nM afimoxifene for 30 minutes
HeLa-S3 treated with interferon alpha for 4 hours
cardiac muscle cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 days
heart embryo (59 days) and female embryo (76 days)
mesodermal cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 2 days, 6 ng/mL Activin A for 2 days, 10 ng/mL Bone morphogenetic protein 4 for 2 days
sigmoid colon female adult (51 years)
heart left ventricle female embryo (101 days) and female embryo (103 days)
endodermal cell
femur female embryo (98 days)
left cardiac atrium female embryo (101 days)
HEK293T
H7
HCT116
skeletal muscle myoblast
KBM-7
H9
BE2C
cerebellum male adult (27 years) and male adult (35 years)
T47D treated with 10 nM 17β-estradiol for 30 minutes
placenta embryo (56 days) and embryo (59 days)
kidney embryo (59 days) and female embryo (59 days)
neural progenitor cell originated from H9
HAP-1
trophoblast cell originated from H1
lung female embryo (76 days)
mesenchymal stem cell originated from H1
neural stem progenitor cell originated from H1
AG04449
eye embryo (56 days) and male embryo (76 days)
OCI-LY7
A549
T47D
dedifferentiated amniotic fluid mesenchymal stem cell male embryo (15 weeks)
Panc1
Ishikawa treated with 10 nM 17β-estradiol for 30 minutes
right kidney male embryo (91 days)
tongue male embryo (72 days)
stomach female adult (51 years)
H1
AG04450
transverse colon female adult (51 years)
B cell female adult (43 years)
upper lobe of left lung male adult (37 years)
placenta female embryo (101 days) and male embryo (105 days)
liver female embryo (101 days) and female embryo (113 days)
cardiac myoblast originated from H7 treated with 10 ng/mL Bone morphogenetic protein 4 for 9 days, 5 ng/mL Fibroblast growth factor 2 for 9 days, 6 ng/mL Activin A for 9 days
H7
trophoblast cell embryo (21 weeks)
stomach male adult (34 years)
hematopoietic multipotent progenitor cell
myotube originated from skeletal muscle myoblast
eye female embryo (76 days)
heart right ventricle female embryo (101 days) and female embryo (103 days)
cardiovascular progenitor cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 5 days, 10 ng/mL Bone morphogenetic protein 4 for 5 days, 6 ng/mL Activin A for 5 days
CD14-positive monocyte female
hepatocyte originated from H9
islet precursor cell
brain embryo (56 days) and male embryo (58 days)
Karpas-422
tibial artery female adult (53 years)
psoas muscle male child (3 years)
occipital lobe male adult (84 years)
fibroblast of lung male adult (45 years)
vagina female adult (53 years)
hematopoietic multipotent progenitor cell treated with interleukin-3 for 13 days, kit ligand for 13 days, hydrocortisone succinate for 13 days, erythropoietin for 13 days
skeletal muscle cell
coronary artery female adult (53 years)
omental fat pad female adult (53 years)
Daoy
heart left ventricle female adult (53 years)
adrenal gland female adult (53 years)
placenta embryo (53 days)
vagina female adult (51 years)
trophoblast cell embryo (23 weeks)
kidney female embryo (76 days) and male embryo (76 days)
keratinocyte female
hematopoietic multipotent progenitor cell
lung embryo (80 days) and male embryo (76 days)
CD1c-positive myeloid dendritic cell
retina female embryo (89 days)
mammary epithelial cell female
brain male embryo (72 days) and male embryo (76 days)
tongue female embryo (59 days) and female embryo (76 days)
testis male adult (54 years)
L1-S8R
hematopoietic multipotent progenitor cell treated with interleukin-3 for 18 days, kit ligand for 18 days, hydrocortisone succinate for 18 days, erythropoietin for 18 days
tibial nerve female adult (51 years)
brain embryo (80 days)
hematopoietic multipotent progenitor cell treated with interleukin-3 for 6 days, kit ligand for 6 days, hydrocortisone succinate for 6 days, erythropoietin for 6 days
heart embryo (80 days)
esophagus muscularis mucosa male adult (37 years)
hematopoietic multipotent progenitor cell treated with interleukin-3 for 11 days, kit ligand for 11 days, hydrocortisone succinate for 11 days, erythropoietin for 11 days
urinary bladder male embryo (76 days)
esophagus squamous epithelium male adult (37 years)
kidney embryo (80 days)
PC-9
NAMALWA treated with Sendai virus for 2 hours
sigmoid colon female adult (53 years)
liver embryo (59 days) and embryo (80 days)
stomach male embryo (58 days) and male embryo (76 days)
hematopoietic multipotent progenitor cell treated with erythropoietin for 20 days, hydrocortisone succinate for 20 days, kit ligand for 20 days, interleukin-3 for 20 days
astrocyte
hematopoietic multipotent progenitor cell treated with interleukin-3 for 4 days, kit ligand for 4 days, hydrocortisone succinate for 4 days, erythropoietin for 4 days
Peyer's patch male adult (37 years)
HeLa-S3 G1b phase
H1
lung male embryo (54 days) and male embryo (58 days)
fibroblast of dermis female adult
